Inventor
FENG JIANWEN A
US30 patents
⚠️ This page may combine multiple inventors who share the name “FENG JIANWEN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DENALI THERAPEUTICS INC
27 patentsUS9815850B2Nov 14, 2017
Compounds, compositions and methods
DENALI THERAPEUTICS INC36 citations97
US9896458B2Feb 20, 2018
Compounds, compositions and methods
DENALI THERAPEUTICS INC23 citations94
US9932325B2Apr 3, 2018
Compounds, compositions, and methods
DENALI THERAPEUTICS INC16 citations92
US11111235B2Sep 7, 2021
Compounds, compositions, and methods
DENALI THERAPEUTICS INC7 citations84
US10590114B2Mar 17, 2020
Compounds, compositions, and methods
DENALI THERAPEUTICS INC5 citations84
US11591316B2Feb 28, 2023
Compounds, compositions, and methods
DENALI THERAPEUTICS INC1 citations73
US10604535B2Mar 31, 2020
Compounds, compositions and methods
DENALI THERAPEUTICS INC3 citations72
US10131676B2Nov 20, 2018
Compounds, compositions and methods
DENALI THERAPEUTICS INC3 citations72
US11306077B2Apr 19, 2022
Compounds, compositions and methods
DENALI THERAPEUTICS INC2 citations71
US11203600B2Dec 21, 2021
Kinase inhibitors and uses thereof
DENALI THERAPEUTICS INC2 citations70
US12358896B2Jul 15, 2025
LRRK2 inhibitors and methods of making and using thereof
DENALI THERAPEUTICS INC0 citations62
US11840529B2Dec 12, 2023
Substituted pyrimidines as LRKK2 inhibitors
DENALI THERAPEUTICS INC0 citations62
US11834439B2Dec 5, 2023
Compounds, compositions, and methods
DENALI THERAPEUTICS INC0 citations62
US11028080B2Jun 8, 2021
Substituted pyrimidines as LRKK2 inhibitors
DENALI THERAPEUTICS INC1 citations62
US12180211B2Dec 31, 2024
Compounds, compositions and methods
DENALI THERAPEUTICS INC0 citations61
US12139478B2Nov 12, 2024
Compounds, compositions and methods
DENALI THERAPEUTICS INC1 citations61
US11851433B2Dec 26, 2023
Compounds, compositions and methods
DENALI THERAPEUTICS INC0 citations61
US11174262B2Nov 16, 2021
Compounds, compositions and methods
DENALI THERAPEUTICS INC0 citations61
US11072618B2Jul 27, 2021
Compounds, compositions and methods
DENALI THERAPEUTICS INC0 citations61
US11958840B2Apr 16, 2024
Compounds, compositions and methods
DENALI THERAPEUTICS INC0 citations60
US11851440B2Dec 26, 2023
Modulators of eukaryotic initiation factor 2B, compositions and methods
DENALI THERAPEUTICS INC0 citations60
US11236100B2Feb 1, 2022
Modulators of eukaryotic initiation factor 2B, compositions and methods
DENALI THERAPEUTICS INC1 citations60
US12358928B2Jul 15, 2025
Compounds, compositions and methods
DENALI THERAPEUTICS INC0 citations59
US12129263B2Oct 29, 2024
Kinase inhibitors and uses thereof
DENALI THERAPEUTICS INC0 citations59
US11214565B2Jan 4, 2022
Compound, compositions, and methods
DENALI THERAPEUTICS INC0 citations52
US12091392B2Sep 17, 2024
Compounds, compositions and methods
DENALI THERAPEUTICS INC0 citations49
US10709692B2Jul 14, 2020
Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1)
DENALI THERAPEUTICS INC0 citations39
GENENTECH INC
3 patentsUS9605005B2Mar 28, 2017
Alkynyl alcohols and methods of use
GENENTECH INC5 citations72
US10654824B2May 19, 2020
2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use
GENENTECH INC0 citations41
US10550117B2Feb 4, 2020
2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use
GENENTECH INC0 citations41